Contact

Representative before the EPO

Company dna wp thompson
no operation time available
1232.55
5 offices
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
4 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 7 EP applications Anne Rachel Burton Williams has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 14, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12722820

PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN CALCIUM

IPC classification:
A61K 31/505, A61K 9/50, A61K 9/20, A61K 9/16
Applicant:
AstraZeneca UK Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
The patent has been granted
EP12727922

PROCESS FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF

IPC classification:
C07D 471/08, C07D 211/60
Applicant:
AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12738589

AZETIDINE DERIVATIVES FOR TREATMENT OF MELANIN RELATED DISORDERS

IPC classification:
A61K 31/407, A61K 31/397, C07D 491/048, C07D 491/044, A61P 3/04
Applicant:
AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14173061

Cyclopropyl amide derivatives

IPC classification:
A61K 31/495, C07D 295/18, C07D 243/08, C07D 239/26, C07D 233/36, C07D 231/12, C07D 211/40, C07D 207/12, A61P 25/00
Applicant:
AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Agent:
Multiple attorneys, Ropes & Gray International LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12841851

METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ATTENTION DEFICIT HYPERACTIVITY DISORDER

IPC classification:
A01N 37/00
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Agent:
Sarah Elizabeth Roques, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13787637

COMPOSITIONS OF STATINS AND OMEGA-3 FATTY ACIDS

IPC classification:
A61K 9/42
Agent:
Anne Rachel Burton Williams, WP Thompson
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
EXAMINATION REQUESTED
EP14772420

THERAPEUTIC POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 31/00, A61K 9/51, A61K 47/12
Agent:
Multiple attorneys, AstraZeneca AB
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
The patent has been granted

Please Sign in to use this feature